Most people with neurodegenerative disease have a mix of protein pathologies in their brain, but there is no easy way to identify them all separately. Indeed, clinicians are urgently awaiting blood ...

Despite modern imaging and genetic testing, diagnosing amyotrophic lateral sclerosis (ALS) remains challenging, particularly ...

Please provide your email address to receive an email when new articles are posted on . Adults with cognitive complaints received usual care by primary care physicians and were tested for blood-based ...

In a study with 991 adults, scientists show that the most common forms of frontotemporal dementia as well as the neurological diseases amyotrophic lateral sclerosis and progressive supranuclear palsy ...

Two blood tests, each involving multiple biomarkers, are highly accurate at identifying Alzheimer's disease pathology in symptomatic patients, supporting diagnosis, according to a new study in ...

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it will offer the Elecsys pTau181 test, the only blood test cleared by the U.S. Food and Drug ...

Peripheral artery disease is a severe form of cardiovascular disease affecting more than 230 million individuals worldwide. The correlation of peripheral artery disease with diminished blood flow in ...

The FDA has cleared Elecsys pTau181, the first blood test for use in primary care to help rule out Alzheimer’s disease in ...

The startup, which has a pair of medicines in testing and others in development, aims to build the “ultimate coagulation ...

With a $157 million series C funding round, Hemab Therapeutics is looking to infuse innovation into the treatment landscape ...